LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | HG-5-88-01 | 10 | uM | LJP6 | 72 | hr | 765 | 2098 | 3101 | 0.6765 | 0.6480 |
Hs 578T | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 765 | 3471 | 3101 | 1.1194 | 1.1150 |
Hs 578T | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 765 | 3351 | 3101 | 1.0806 | 1.0782 |
Hs 578T | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 765 | 2937 | 3101 | 0.9467 | 0.9456 |
Hs 578T | HG-6-64-01 | 1.11 | uM | LJP6 | 72 | hr | 765 | 1522 | 3101 | 0.4905 | 0.4051 |
Hs 578T | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 765 | 568 | 3101 | 0.1834 | -0.1389 |
Hs 578T | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 765 | 174 | 3101 | 0.0564 | -0.5216 |
Hs 578T | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 765 | 2797 | 3148 | 0.8887 | 0.8876 |
Hs 578T | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 2591 | 3148 | 0.8232 | 0.8180 |
Hs 578T | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 2248 | 3148 | 0.7143 | 0.6952 |
Hs 578T | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 765 | 2244 | 3148 | 0.7130 | 0.6939 |
Hs 578T | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 1654 | 3148 | 0.5255 | 0.4592 |
Hs 578T | Neratinib | 10 | uM | LJP5 | 72 | hr | 765 | 1001 | 3148 | 0.3180 | 0.1380 |
Hs 578T | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 765 | 2902 | 3101 | 0.9355 | 0.9348 |
Hs 578T | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 765 | 2846 | 3101 | 0.9179 | 0.9169 |
Hs 578T | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 765 | 2476 | 3101 | 0.7985 | 0.7891 |
Hs 578T | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 765 | 1915 | 3101 | 0.6176 | 0.5753 |
Hs 578T | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 765 | 1466 | 3101 | 0.4728 | 0.3800 |
Hs 578T | JW-7-24-1 | 10 | uM | LJP6 | 72 | hr | 765 | 414 | 3101 | 0.1335 | -0.2622 |
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 765 | 1862 | 3148 | 0.5915 | 0.5462 |
Hs 578T | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 765 | 1008 | 3101 | 0.3250 | 0.1452 |
Hs 578T | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 1134 | 3148 | 0.3602 | 0.2125 |
Hs 578T | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 765 | 531 | 3101 | 0.1711 | -0.1664 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 524 | 3148 | 0.1667 | -0.1690 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 765 | 509 | 3101 | 0.1641 | -0.1829 |